Adaptation of the quadrupole mass spectrometer to multipatient anaesthesia gas monitoring

Model-based administration of inhalation anaesthesia. 3. Validating the system model

BACKGROUND

We quantified the predictive performance of our computer model of the administration of inhalation anaesthesia from a Datex-Ohmeda Modulus CD circle-absorber system.

METHODS

In 50 patients, desflurane anaesthesia was maintained with a fresh-gas flow (FGF) of 0.5 litres min(-1) of both nitrous oxide and oxygen, preceded by fast (n=14) or slow (n=36) induction: FGF greater than total ventilation, Group F; FGF equal to 1.0 litres min(-1), Group S. The two versions of the model studied differed in the size of their inter-tissue diffusion, as 0 (version 1) and 3% (version 2) of the cardiac output was shifted from the viscera to adipose tissue. Model performance was judged by comparing measured and predicted gas concentrations in terms of three variables for each gas concentration in each patient: root mean squared error (rmse=total error), bias (mean predicted - measured) (systematic error), and scatter (error around bias). These variables were then averaged over all patients. These measures were calculated overall, and separately for each group and each stage (1 = induction or 2 = maintenance).

RESULTS

Model predictions were in reasonable to very good agreement with clinically obtained data. Version 2 performed better than version 1. Differences between groups were not demonstrated. The model performed better for stage 2, but only for desflurane. In group S, results (mean (SD); as percentages of the measured values for nitrous oxide, oxygen and desflurane) in the order rmse, bias, and scatter were for end-tidal concentrations of nitrous oxide: 8 (4), 8 (5), 2 (1)%; oxygen: 11 (4), -10 (6), 2 (1.1)%; nitrogen: 0.9 (0.6), -0.8 (0.6), 0.2 (0.1) vol%; carbon dioxide: 1.8 (0.6), 1.8 (0.6), 0.2 (0.1) vol%; desflurane, stage 2: 8 (4), 4 (7), 4 (2)%, vs 15 (6), -10 (8), 9 (4)% for stage 1.

CONCLUSION

Administration of inhalation anaesthesia can be based on version 2 of this model, but must be guided by active monitoring.

Evaluation of long sampling tubes for remote monitoring by mass spectrometry

The long sampling tubes required for remote mass spectrometry alter the sampling system's performance characterized by sample flow, residence time, and 10 to 90% response time. We searched for an easy-to-handle tube with (1) a length of 30 m, (2) sample flow less than 50 ml.min-1, and (3) residence and response times approaching those predicted by our mathematical model. We tested tubes of various geometries and various commercially available materials by using them as inlet catheters for a quadrupole mass spectrometer (Centronic 200 MGA, Centronic Ltd, Craydon, UK). We measured their responses at 0 to 10% (on transients) and 10 to 0% (off transients) step changes in gas concentration for nitrogen, argon, nitrous oxide, oxygen, and carbon dioxide and 0 to 3% and 3 to 0% for halothane, enflurane, and isoflurane. With 5 polyethylene tubes, halothane response times were up to 38 times longer than predicted. One 30-m polyethylene tube combined a 158-ms response time for nitrogen and argon with a 2,205-ms response time for halothane. Teflon, polyvinyl chloride, and stainless steel also proved to be unsuitable because of unacceptable signal distortion: the carbon dioxide response time for a 30-m Teflon tube was 2,600 ms. A glass tube showed the least signal distortion but was hard to handle. Our requirements were fulfilled by a 29.77-m tube made from nylon with a 1.00-mm inside diameter to which a 0.23-m length of nylon with a 0.25-mm inside diameter was added at the patient end. It offers (1) sample flow equals 46 ml.min-1, (2) residence time equals 11.1 seconds, and (3) response times approaching our theoretical predictions, that is, 159, 164, 180, 159, 188, 302, 298, and 300 ms (means of on and off transients) for nitrogen, argon, nitrous oxide, oxygen, carbon dioxide, halothane, enflurane, and isoflurane, respectively. This tube allows the accurate monitoring of breathing frequencies up to 25 and 50 breaths/min for volatile agents and gases, respectively.

Ventilation and ventilators--an update

In the five years which have passed since the previous review, the literature has been concerned more with the ways in which ventilators may be applied to patients and the effects of differing patterns of ventilation than with the design philosophy of the ventilators themselves. This account should be read in conjunction with that of 1982 [1].